⌘K

Login Start Free

Home/Filings/4/0001415889-25-000155

4//SEC Filing

Stuart Iain 4

Accession 0001415889-25-000155

CIK 0001566044other

View on SEC.gov Company Profile

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 5:45 PM ET

Size

5.2 KB

Accession

0001415889-25-000155

Insider Transaction Report

Form 4

Period: 2024-12-31

VYNE Therapeutics Inc.VYNE

CHIEF SCIENTIFIC OFFICER

Transactions

Tax Payment
Common Stock
2024-12-31$3.35/sh−4,857$16,271→ 128,637 total

Footnotes (1)

[F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Documents

1 file

4
form4-01022025_050105.xmlPrimary

Issuer

VYNE Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1

filerCIK 0001727756

Filing Metadata

Form type: 4
Filed: Jan 1, 7:00 PM ET
Accepted: Jan 2, 5:45 PM ET
Size: 5.2 KB

View on SEC.gov